Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Biotech News Editors

News Widget

Display the Biotech news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Biotech News

Biotech news continually updated from thousands of sources around the net.

3 hrs ago | Bloomberg

Valeant Said to Be Near Deal to Buy Bausch & Lomb for $9 Billion

Valeant Pharmaceuticals International Inc. , Canada 's largest drugmaker, is close to acquiring Bausch & Lomb Holdings Inc., the eye-care company owned by Warburg Pincus LLC, for about $9 billion, according to a person familiar with the negotiations.

Comment?

Related Topix: 9, Valeant Pharmaceuticals International, Startups, Warburg Pincus, Wall Street Systems

Fri May 24, 2013

My Mother Lode

San Diego mayor has plan to end bird poop stink

San Diego officials have announced a plan to rid the scenic beaches of La Jolla of bird poop smell after declaring the excrement a health hazard.

Comment?

Related Topix: San Diego, CA, La-Jolla, CA, La Jolla Pharmaceutical, Medicine, Healthcare Industry

Seattle Times

Pharmaceutical co. ISTA pleads in NY federal case

ISTA Pharmaceuticals Inc. pleaded guilty on Friday in a federal case involving its eye drug Xibrom, admitting it promoted the drug for unapproved uses and agreeing to pay $33.5 million in fines and fees.

Comment?

Related Topix: Medicine, ISTA Pharmaceuticals, Healthcare Industry, Bausch and Lomb, Medical Equipment, Healthcare Law, Law, Marketing

BioSpace

Merck Serono Scouting Biotech Opportunities

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Stefan Oschmann came courting biotechnology start-ups last week, a trans-Atlantic visitor promising not only pharmaceutical industry expertise but also cash.

Comment?

Related Topix: Merck , Medicine, Science / Technology, Healthcare Industry, Millipore

WHTC

Novo obesity drug could launch in U.S. end 2014

Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential.

Comment?

Related Topix: Novo Nordisk AS, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health

The Hartford Courant

Forest Labs' longtime CEO Solomon to step down at year-end

Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company morph from a small generic and vitamins maker to a $10 billion corporation.

Comment?

Related Topix: Medicine, Forest Labs, Healthcare Industry, Ansonia, CT

California Computer News

Molecule That Triggers Sensation of Itch Found

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.

Comment?

Related Topix: National Institutes of Health, Medicine, Healthcare Industry

Thu May 23, 2013

Seattle Post-Intelligencer

J&J expects 10-plus new drug applications by 2017

Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during a review of the health care giant's medicine business.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Seattle Post-Intelligencer

News Summary: J&J predicts surge of new medicines

BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

USA Today

Majority of Superstorm Sandy deaths were from drowning

Drowning was the most common cause of death associated with the Oct. 29 Superstorm Sandy, according to a new report out Thursday from Centers for Disease Control and Prevention.

Comment?

Related Topix: Centers for Disease Control and Prevention, Control Group, Medicine, Healthcare Industry, Hurricane, Weather, Hurricane Sandy, Queens, NY, New York, NY

Bioscience Technology

FDA panel backs experimental Merck insomnia drug

A federal panel of medical experts said that an experimental insomnia drug from Merck & Co.

Comment?

Related Topix: Food and Drug Administration, Merck , Medicine, Healthcare Industry, Insomnia, Health

Philly.com

J&J forecasts 10 new drug applications by 2017

Johnson & Johnson says it plans to submit more than 10 new treatments to regulators for approval and 25 applications for additional uses of approved drugs by 2017.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

WKYT

Nearly all US states see hefty drop in teen births

A report by the Centers for Disease Control and Prevention is showing a big drop in teen birth rates that some experts say is startling.

Comment?

Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

The Hartford Courant

Pfizer takes its shot at a vaccine for evasive superbug

Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.

Comment?

Related Topix: Vaccinations, Health, Pfizer, Medicine, Healthcare Industry, Merck , MRSA, Nabi Biopharmaceuticals

Wed May 22, 2013

Seattle Times

Pfizer plans offering to pare Zoetis stake

Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.

Comment?

Related Topix: Pfizer, Medicine, Healthcare Industry, Financial Markets, Life, Food, Nutrition, Madison, NJ

Common Dreams

Pesticide Producers Turn to 'Bee-Washing' to Fight Backlash

Pesticide makers have taken to framing themselves as stewards of the bees as backlash over their products' links to mass bee deaths grows.

Comment?

Related Topix: Apiculture, Science, Agriculture, Manufacturing, Bayer AG, Chemicals, Monsanto, Entomology, US News, Liberal Political News

Science Daily

Phthalates -- chemicals widely found in plastics and processed food...

Once perceived as harmless, phthalates have come under increasing scrutiny. A growing collection of evidence suggests dietary exposure to phthalates may cause significant metabolic and hormonal abnormalities, especially during early development.

Comment?

Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry, University of Washington

Philly.com

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Comment?

Related Topix: GlaxoSmithKline, Medicine, Healthcare Industry

Reuters

Immune system cancer drugs tipped to be a $35 billion market

A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.

Comment?

Related Topix: Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Pharmaceuticals, Healthcare Industry, Healthcare Law, Law

Drug Researcher

Impax Hires Specialists to Help Sort Manufacturing Issues

Faced with manufacturing quality questions that caused the FDA to reject its potential Parkinson's disease treatment, Impax Laboratories has hired a committee of specialists to oversee quality improvements at its California facility.

Comment?

Related Topix: Impax Laboratories, Medicine, Pharmaceuticals, Healthcare Industry, Parkinson's Disease, Health, Hayward, CA

Biotech Jobs